Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma

Ming-Hung Hu1,2,3, Tzu-Ting Huang4, Tzu-I Chao5

  • 1Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.

Abstract

Insights

Protein phosphatase 5 (PP5) promotes cholangiocarcinoma (CCA) growth by inhibiting AMP-activated protein kinase (AMPK). Inhibiting PP5 with compounds like norcantharidin (NCTD) suppressed tumor growth, highlighting PP5 as a potential therapeutic target for CCA.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cholangiocarcinoma (CCA) has limited actionable drug targets.
  • Dysregulation of Serine/threonine protein phosphatase 5 (PP5) is implicated in various cancers.
  • The specific role of PP5 in CCA pathogenesis remains largely undefined.

Purpose of the Study:

  • To investigate the role of PP5 in CCA tumorigenesis.
  • To evaluate PP5 inhibitors as a potential therapeutic strategy for CCA.
  • To elucidate the molecular mechanisms underlying PP5's function in CCA.

Main Methods:

  • Utilized colony and tumorsphere formation assays to assess CCA cell growth.
  • Employed PP5 inhibitors Cantharidin (CTD) and norcantharidin (NCTD) in vitro and in vivo.
  • Performed PP5 overexpression and knockdown studies, including shRNA-mediated knockdown in xenograft models.
  • Investigated the interaction between PP5 and AMP-activated protein kinase (AMPK) via immunoprecipitation.

Main Results:

  • PP5 overexpression increased CCA cell growth and colony formation, while PP5 knockdown reduced these.
  • PP5 knockdown in xenografts decreased tumor growth and increased AMPK phosphorylation.
  • CTD treatment reduced CCA cell viability, PP5 activity, and enhanced AMPK phosphorylation.
  • PP5 negatively regulates AMPK phosphorylation; PP5 inhibition or AMPK suppression affected CTD-induced cell death.
  • NCTD treatment in vivo suppressed PP5, increased p-AMPK, and reduced tumor volume in CCA xenografts.

Conclusions:

  • Protein phosphatase 5 (PP5) negatively regulates AMPK phosphorylation.
  • PP5 contributes to CCA aggressiveness and tumorigenesis.
  • PP5 represents a promising therapeutic target for cholangiocarcinoma treatment.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.7K
5-Number Summary01:04

5-Number Summary

In a dataset, the 5-number summary includes the minimum data value, the data value of the first quartile, the median data value or data value of the second quartile, the data value of the third quartile, and the maximum data value. These 5 data values can be visualized as a box and whisker plot.
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
5.7K
The Resting Membrane Potential01:21

The Resting Membrane Potential

Overview
143.1K
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K